UNILEX (UNILEX) fundamentals

UNILEX is a listed company, part of the Chemicals sector, listed on the NSE as UNILEX (ISIN INE0B2801011). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.

What UNILEX does

Unilex Colours and Chemicals Limited is engaged in the business of manufacturing pigments, and the trading of chemicals and food colors. The pigments manufactured by the Company find diverse applications across various industries, such as plastic, rubber, textiles, paper, printing inks, paints and coatings. Its product portfolio includes a range of pigments, including Pigment Green -7, Pigment middle chrome, Pigment Violet 23 & 27 and Ultramarine Blue. Its products are marketed under the registered brand name Unilex. Within Pigments, the Company specializes in Pigment Blue 15:3 and 15:4, with an annual production capacity of 1878 mtpa. It provides flexible packing options such as multi-layer paper bags, corrugated boxes, HDPE and HDPE coated bags, multilayer abetted liners and HM covers, wooden pallets and jumbo bags, among others. It caters to both domestic and international markets. It has two plants based in Tarapur industrial city and one plant in Wada district, Maharashtra state.

Valuation and market data

Last close₹28.00
Market capitalisation₹33 crore
Enterprise value₹4 crore
P/E (TTM)1.32
Price to book0.46
Price to sales (TTM)0.06
Book value per share₹60.29
Dividend yield0.00%
SectorChemicals
Industry

Annual results

PeriodRevenueProfit before taxNet profitEPS
Mar 2026₹153 crore₹10 crore₹8 crore0.00

Figures are as reported (consolidated), in ₹ crore.

Shareholding pattern

As of Mar 2026:

Promoters73.6%
Foreign institutions (FII)0.0%
Mutual funds0.0%
Other domestic institutions1.1%
Retail and others25.4%

More on BreakPoint

FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.

Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.